enGene Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
ENGN Key Statistics
Stock Snapshot
The current enGene Therapeutics Inc.(ENGN) stock price is $1.58, with a market capitalization of 105.89M. The stock trades at a price-to-earnings (P/E) ratio of -0.75.
During the trading session on 2026-10-26, enGene Therapeutics Inc.(ENGN) shares reached a daily high of $1.63 and a low of $1.55. At a current price of $1.58, the stock is +1.7% higher than the low and still -2.8% under the high.
Trading volume for enGene Therapeutics Inc.(ENGN) stock has reached 656.88K, versus its average volume of 895.46K.
The stock's 52-week range extends from a low of $1.40 to a high of $12.25.
The stock's 52-week range extends from a low of $1.40 to a high of $12.25.
Analyst ratings
60%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.